185 related articles for article (PubMed ID: 36551241)
21. G protein-coupled receptor interactions and modification of signalling involving the ghrelin receptor, GHSR1a.
Ringuet MT; Furness JB; Furness SGB
J Neuroendocrinol; 2022 Sep; 34(9):e13077. PubMed ID: 34931385
[TBL] [Abstract][Full Text] [Related]
22. The emerging role of heterodimerisation and interacting proteins in ghrelin receptor function.
Price ML; Ley CD; Gorvin CM
J Endocrinol; 2021 Nov; 252(1):R23-R39. PubMed ID: 34663757
[TBL] [Abstract][Full Text] [Related]
23. Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor.
Johansson S; Fredholm BB; Hjort C; Morein T; Kull B; Hu PS
Biochem Pharmacol; 2005 Aug; 70(4):598-605. PubMed ID: 15979585
[TBL] [Abstract][Full Text] [Related]
24. Expression of ghrelin and ghrelin functional receptor GHSR1a in human pituitary adenomas.
Andrusiewicz M; Komarowska H; Skibińska I; Chmielewska M; Jaskuła-Świtek M; Liebert W; Waśko R; Kotwicka M
Pol Arch Intern Med; 2017 Mar; 127(3):163-169. PubMed ID: 28377557
[TBL] [Abstract][Full Text] [Related]
25. MRAP2 regulates ghrelin receptor signaling and hunger sensing.
Srisai D; Yin TC; Lee AA; Rouault AAJ; Pearson NA; Grobe JL; Sebag JA
Nat Commun; 2017 Sep; 8(1):713. PubMed ID: 28959025
[TBL] [Abstract][Full Text] [Related]
26. LEAP2 has antagonized the ghrelin receptor GHSR1a since its emergence in ancient fish.
Li HZ; Shou LL; Shao XX; Li N; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2021 Jun; 53(6):939-949. PubMed ID: 33966114
[TBL] [Abstract][Full Text] [Related]
27. Blocking constitutive activity of GHSR1a in the lateral amygdala facilitates acquisition of conditioned taste aversion.
Li N; Song G; Wang Y; Zhu Q; Han F; Zhang C; Zhou Y
Neuropeptides; 2018 Apr; 68():22-27. PubMed ID: 29254662
[TBL] [Abstract][Full Text] [Related]
28. Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor.
Callaghan B; Kosari S; Pustovit RV; Sartor DM; Ferens D; Ban K; Baell J; Nguyen TV; Rivera LR; Brock JA; Furness JB
Br J Pharmacol; 2014 Mar; 171(5):1275-86. PubMed ID: 24670149
[TBL] [Abstract][Full Text] [Related]
29. Initial Pharmacological Characterization of a Major Hydroxy Metabolite of PF-5190457: Inverse Agonist Activity of PF-6870961 at the Ghrelin Receptor.
Deschaine SL; Hedegaard MA; Pince CL; Farokhnia M; Moose JE; Stock IA; Adusumalli S; Akhlaghi F; Hougland JL; Sulima A; Rice KC; Koob GF; Vendruscolo LF; Holst B; Leggio L
J Pharmacol Exp Ther; 2023 Aug; 386(2):117-128. PubMed ID: 36631279
[TBL] [Abstract][Full Text] [Related]
30. Ghrelin receptor signaling in health and disease: a biased view.
Gross JD; Zhou Y; Barak LS; Caron MG
Trends Endocrinol Metab; 2023 Feb; 34(2):106-118. PubMed ID: 36567228
[TBL] [Abstract][Full Text] [Related]
31. A new understanding of GHSR1a--independent of ghrelin activation.
Xiao X; Bi M; Jiao Q; Chen X; Du X; Jiang H
Ageing Res Rev; 2020 Dec; 64():101187. PubMed ID: 33007437
[TBL] [Abstract][Full Text] [Related]
32. Discovery of a functionally selective ghrelin receptor (GHSR
Gross JD; Kim DW; Zhou Y; Jansen D; Slosky LM; Clark NB; Ray CR; Hu X; Southall N; Wang A; Xu X; Barnaeva E; Wetsel WC; Ferrer M; Marugan JJ; Caron MG; Barak LS; Toth K
Proc Natl Acad Sci U S A; 2022 Mar; 119(10):e2112397119. PubMed ID: 35239443
[TBL] [Abstract][Full Text] [Related]
33. Analysis of expression and structure of the rat GH-secretagogue/ghrelin receptor (Ghsr) gene: roles of epigenetic modifications in transcriptional regulation.
Inoue H; Sakamoto Y; Kangawa N; Kimura C; Ogata T; Fujieda K; Qian ZR; Sano T; Itakura M
Mol Cell Endocrinol; 2011 Oct; 345(1-2):1-15. PubMed ID: 21756973
[TBL] [Abstract][Full Text] [Related]
34. Ghrelin and LEAP-2: Rivals in Energy Metabolism.
Al-Massadi O; Müller T; Tschöp M; Diéguez C; Nogueiras R
Trends Pharmacol Sci; 2018 Aug; 39(8):685-694. PubMed ID: 30037389
[TBL] [Abstract][Full Text] [Related]
35. GHSR1a deficiency suppresses inhibitory drive on dCA1 pyramidal neurons and contributes to memory reinforcement.
Li N; Li N; Yang L; Gu H; Ji J; Zhou H; Zhu Q; Yu M; Sun Y; Zhou Y
Cereb Cortex; 2023 Mar; 33(6):2612-2625. PubMed ID: 35797708
[TBL] [Abstract][Full Text] [Related]
36. Silencing of ghrelin receptor expression inhibits endometrial cancer cell growth in vitro and in vivo.
Fung JN; Jeffery PL; Lee JD; Seim I; Roche D; Obermair A; Chopin LK; Chen C
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E305-13. PubMed ID: 23736537
[TBL] [Abstract][Full Text] [Related]
37. Novel and conventional receptors for ghrelin, desacyl-ghrelin, and pharmacologically related compounds.
Callaghan B; Furness JB
Pharmacol Rev; 2014 Oct; 66(4):984-1001. PubMed ID: 25107984
[TBL] [Abstract][Full Text] [Related]
38. Ghrelin upregulates the phosphorylation of the GluN2B subunit of the NMDA receptor by activating GHSR1a and Fyn in the rat hippocampus.
Berrout L; Isokawa M
Brain Res; 2018 Jan; 1678():20-26. PubMed ID: 28993142
[TBL] [Abstract][Full Text] [Related]
39. Ghrelin inhibits ovarian epithelial carcinoma cell proliferation in vitro.
Xu Y; Pang X; Dong M; Wen F; Zhang Y
Oncol Rep; 2013 Nov; 30(5):2063-70. PubMed ID: 23982275
[TBL] [Abstract][Full Text] [Related]
40. Apo-Ghrelin Receptor (apo-GHSR1a) Regulates Dopamine Signaling in the Brain.
Kern A; Grande C; Smith RG
Front Endocrinol (Lausanne); 2014; 5():129. PubMed ID: 25183960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
